USFDA okays Mylan, Biocon's biosimilar of cancer drug Herceptin

Ogivri is the first USFDA approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the US.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news